Evidence supporting the use of: Hydrogen
For the health condition: Radiation Sickness
Synopsis
Source of validity: Scientific
Rating (out of 5): 2
Hydrogen, specifically in the form of molecular hydrogen (H2), has been investigated in recent years for its potential therapeutic effects against radiation-induced damage. The scientific interest arises from hydrogen's selective antioxidant properties, particularly its ability to neutralize harmful hydroxyl radicals (•OH) generated during ionizing radiation exposure. Several preclinical studies in cellular and animal models have shown that administration of hydrogen-rich saline or inhaled hydrogen gas can reduce oxidative stress, decrease inflammation, and protect tissues from radiation-induced injury. For example, studies published in peer-reviewed journals such as Free Radical Research and Medical Gas Research have demonstrated that hydrogen treatment can alleviate symptoms of acute radiation sickness, improve survival rates, and reduce damage to organs such as the gastrointestinal tract and bone marrow in irradiated animals.
Despite these promising findings, clinical evidence in humans is minimal. There are only a few small-scale or preliminary clinical studies, and no large randomized controlled trials have been completed to establish efficacy and safety in humans suffering from radiation sickness. Thus, while the scientific rationale and early preclinical data support a possible benefit, the overall level of evidence remains low (rated 2/5). Hydrogen is not part of standard medical protocols for treating radiation sickness, and more research is needed before it can be recommended for this use in clinical practice.
Other ingredients used for Radiation Sickness
alpha-ketoglutarate (AKG)astragalus
Beta-Glucan
catalase
caterpillar mushroom
d-alpha tocopherol
iodine
kelp
l-carnosine
l-glutathione
potassium
spirulina
vitamin C
vitamin E
seaweed
β-nicotinamide mononucleotide (NMN)
Astragaloside
Alkylglycerols
Dithiolthiones
Folinic Acid
Glutamine